Novartis International AG /
Novartis drug Afinitor® significantly improves progression-free survival in
advanced nonfunctional gastrointestinal and lung NET
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.
...
↧